About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.

Website: http://www.worldwide.com

Employees: 3419

HQ: (610) 964-2000

Location: Durham, NC, US

Revenue: $600 million

Worldwide Michael Murphy Clinical Trials is a leading global Contract Research Organization (CRO) that provides top-notch clinical development services to the biotechnology and pharmaceutical industries. With a rich history spanning over 30 years, the company has established itself as a trusted partner in the field of clinical research, offering a wide range of services from early phase and bioanalytical sciences through late phase studies, post-approval, and real-world evidence. Headquartered in Durham, North Carolina, Worldwide Michael Murphy Clinical Trials boasts a strong presence across 60 countries, with offices in North and South America, Eastern and Western Europe, Russia, and Asia. The company's impressive infrastructure is complemented by its team of over 2,600 expert employees, who are dedicated to advancing medical science and improving patient outcomes. The company's focus on cutting-edge research is evident in its work in major therapeutic areas such as Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases. Their commitment to innovation and excellence has earned them a reputation as a trusted partner for biotechnology and pharmaceutical companies looking to advance their clinical development programs. Worldwide Michael Murphy Clinical Trials' success is also reflected in its strong financial performance, with a revenue of $100 - 500 Million and a size of 1000 - 4999 employees. The company's dedication to providing top-quality services has earned them a loyal customer base, and their commitment to advancing medical science has made them a valuable asset to the healthcare industry as a whole. In conclusion, Worldwide Michael Murphy Clinical Trials is a premier CRO that offers a comprehensive range of clinical development services to the biotechnology and pharmaceutical industries. With a strong presence across the globe, a talented team of experts, and a commitment to innovation, the company is well-positioned to continue leading the way in clinical research for years to come.

Worldwide Clinical Trials is a global company that helps biotechnology and pharmaceutical companies develop new drugs and treatments. They have been in business since 1986 and have a team of over 2,600 experts working in 60 countries. They offer a range of services, including early stage testing, clinical trials, and post-approval studies. They specialize in several areas, including heart disease, metabolic disorders, neuroscience, cancer, and rare diseases. They have offices in North and South America, Europe, Russia, and Asia. Their goal is to provide high-quality services to help bring new treatments to market. You can learn more about them by visiting their website at www.worldwide.com.